| Stage | CVNA | % of rev | KMX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $7.9B | 100.00% | CVNA ×1.02 |
| Gross profit | $1.5B | 18.92% | $799M | 10.15% | CVNA +8.8pp |
| Operating income | $714M | 8.88% | $101M | 1.28% | CVNA +7.6pp |
| Pre-tax income | $552M | 6.87% | $223M | 2.83% | CVNA +4.0pp |
| Net income | $483M | 6.01% | $165M | 2.10% | CVNA +3.9pp |
| Stage | CVNA | KMX | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $7.9B100.00% | CVNA ×1.02 |
| Gross profit | 18.92%$1.5B | 10.15%$799M | CVNA +8.8pp |
| Operating income | 8.88%$714M | 1.28%$101M | CVNA +7.6pp |
| Pre-tax income | 6.87%$552M | 2.83%$223M | CVNA +4.0pp |
| Net income |
| 6.01%$483M |
| 2.10%$165M |
| CVNA +3.9pp |
No shared counterparties.